Toray Develops Porous Fibers for Adsorbing Pathogenic Substances in Intractable Diseases
NQ Score
51/100
AI Summary (NQ-processed)
Toray has developed a technology to control the pore size of PMMA porous fibers up to 1,000nm. This enables the selective adsorption of large-molecule pathogenic substances. The technology aims to provide new blood purification treatment options for intractable diseases.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What diseases is this technology applicable to?
- A: It is intended for intractable diseases such as autoimmune disorders, cardiovascular metabolic diseases, neurodegenerative diseases, and cancer.
- Q: How does it differ from conventional fibers?
- A: It can control pore sizes up to approximately 1,000nm, enabling the removal of large-molecule pathogenic substances that conventional fibers could not capture.